510(k) K170623
K170623 is an FDA 510(k) premarket notification submitted by Alfa Wassermann Diagnostic Technologies, LLC for the device "ACE Hemoglobin A1c (HbA1c) Reagent". The FDA issued a decision of Substantially Equivalent on February 27, 2018. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470. Alfa Wassermann Diagnostic Technologies, LLC has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 27, 2018
- Date Received
- March 1, 2017
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Assay, Glycosylated Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type